Clinical Trial Update: A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating the efficacy and safety of anaprazole for duodenal ulcers is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer

Drugs mentioned

• Anaprazole

Snippet

Sponsor: Sihuan Pharmaceutical Holdings Group Ltd. | Conditions: Duodenal Ulcer，DU | Phase 3 | Status: UNKNOWN